ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$QTTB:NASDAQ · Q32 Bio Inc

Sector: health

Conviction from: NASDAQ

52-week range: 1.9123.57

Clinical-stage immunology and inflammation biotech

2 tracked filer(s) hold this · 1 opened, 0 added, 1 trimmed in 30-JUN-2026

Aggregate 13FScore 60 — mean of 2 scored holder(s) · buyers (new/add) avg 75. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7275New buy1,173,396$14,949,0650.0%
Carlyle Group Inc. (auto-surfaced)44Trimmed -95%60,363$769,0200.0%

Beyond 13F — activists, insiders, politicians & research

Activist 13D filings daily digest →

FiledFormActivist% of classConviction
2026-05-06SCHEDULE 13D/AORBIMED ADVISORS LLC13.3%Highfiling
2026-03-12SCHEDULE 13D/AORBIMED ADVISORS LLC15.4%Highfiling

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-10-17.